Delivery Order SPE2DB22D2103-SPE2DB25FR9SS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $8,590.58 with a firm fixed price contract type. The award is non-set-aside and represents a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialized pharmaceutical used primarily in the treatment of pulmonary fibrosis and other...
- The Defense Logistics Agency awarded a $17,220.86 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The contract is set to be completed by September 8, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8.63K to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ofev 100 mg capsules (60-count units). This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The award is non-competitive and utilizes firm fixed pricing for this pharmaceutical delivery....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract specifies performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ofev 100 mg capsules (60-count) with a ceiling value of $8,630.28. This firm fixed-price delivery order is set to be completed by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating AmerisourceBergen's continued capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $17,181.16. This firm fixed-price delivery order, which is not associated with any set-aside program, is scheduled for completion by July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger federal...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9SSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 60 capsules of Ofev 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The order carries a ceiling value of $17,181.16 under a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award represents a non-set-aside, competitively awarded contract issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical supplier for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains, positioning it as a primary vendor for the Defense Logistics Agency's pharmaceutical support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 8/26/25 |